Showing results (311-320 of 458) with videos related to

Sort By:
Pageof 46
Cancer|August 1, 2013
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology GroupLarry L Wang, Rie Suganuma, Naohiko Ikegaki, et al.
Bioinformatics (Oxford, England)|January 18, 2018
QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstructionPaul Deveau, Leo Colmet Daage, Derek Oldridge, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastomaKristina A Cole, Jonathan Huggins, Michael Laquaglia, et al.
Oncotarget|June 9, 2015
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanismStefano J Mandriota, Linda J Valentijn, Laurence Lesne, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effectL Feinstein, B Sandmaier, D Maloney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641Douglas R Strother, Wendy B London, Mary Lou Schmidt, et al.
Nature Communications|December 11, 2019
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitryLu Wang, Tze King Tan, Adam D Durbin, et al.
Pediatric Blood & Cancer|November 6, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531Julie Voeller, Howard M Katzenstein, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2025
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group StudyEsther R Berko, Arlene Naranjo, Alexander A Daniels, et al.
BMC Bioinformatics|December 15, 2020
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusionsKrutika S Gaonkar, Federico Marini, Komal S Rathi, et al.
Pageof 46